gefitinib has been researched along with 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) | Trials (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) | Recent Studies (post-2010) (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 1,928 | 1 | 1,354 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcantara, LM; Ayong, LS; Franco, CH; Franzoi, KD; Freitas-Junior, LH; Kim, J; Lee, S; Moraes, CB | 1 |
1 other study(ies) available for gefitinib and 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
| Article | Year |
|---|---|
Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites.
Topics: Antimalarials; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Boron Compounds; Chloroquine; Chlorpheniramine; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Erythrocytes; Fluorescent Dyes; Gefitinib; Humans; Imatinib Mesylate; Mefloquine; Piperazines; Plasmodium falciparum; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Quinolines | 2013 |